Literature DB >> 29222946

Triheptanoin protects against status epilepticus-induced hippocampal mitochondrial dysfunctions, oxidative stress and neuronal degeneration.

Kah Ni Tan1, David Simmons1, Catalina Carrasco-Pozo2,3, Karin Borges1.   

Abstract

Triheptanoin, the triglyceride of heptanoate, is anaplerotic (refills deficient tricarboxylic acid cycle intermediates) via the propionyl-CoA carboxylase pathway. It has been shown to be neuroprotective and anticonvulsant in several models of neurological disorders. Here, we investigated the effects of triheptanoin against changes of hippocampal mitochondrial functions, oxidative stress and cell death induced by pilocarpine-induced status epilepticus (SE) in mice. Ten days of triheptanoin pre-treatment did not protect against SE, but it preserved hippocampal mitochondrial functions including state 2, state 3 ADP, state 3 uncoupled respiration, respiration linked to ATP synthesis along with the activities of pyruvate dehydrogenase complex and oxoglutarate dehydrogenase complex 24 h post-SE. Triheptanoin prevented the SE-induced reductions of hippocampal mitochondrial superoxide dismutase activity and plasma antioxidant status as well as lipid peroxidation. It also reduced neuronal degeneration in hippocampal CA1 and CA3 regions 3 days after SE. In addition, heptanoate significantly reduced hydrogen peroxide-induced cell death in cultured neurons. In situ hybridization localized the enzymes of the propionyl-CoA carboxylase pathway, specifically Pccα, Pccβ and methylmalonyl-CoA mutase to adult mouse hippocampal pyramidal neurons and dentate granule cells, indicating that anaplerosis may occur in neurons. In conclusion, triheptanoin appears to have anaplerotic and antioxidant effects which contribute to its neuroprotective properties.
© 2017 International Society for Neurochemistry.

Entities:  

Keywords:  mitochondrial function; neuroprotection; oxidative stress; pilocarpine; triheptanoin

Mesh:

Substances:

Year:  2018        PMID: 29222946     DOI: 10.1111/jnc.14275

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  8 in total

1.  Triheptanoin alters [U-13C6]-glucose incorporation into glycolytic intermediates and increases TCA cycling by normalizing the activities of pyruvate dehydrogenase and oxoglutarate dehydrogenase in a chronic epilepsy mouse model.

Authors:  Tanya McDonald; Mark P Hodson; Ilya Bederman; Michelle Puchowicz; Karin Borges
Journal:  J Cereb Blood Flow Metab       Date:  2019-03-19       Impact factor: 6.200

2.  Medium branched chain fatty acids improve the profile of tricarboxylic acid cycle intermediates in mitochondrial fatty acid β-oxidation deficient cells: A comparative study.

Authors:  Anuradha Karunanidhi; Clinton Van't Land; Dhivyaa Rajasundaram; Mateus Grings; Jerry Vockley; Al-Walid Mohsen
Journal:  J Inherit Metab Dis       Date:  2022-02-02       Impact factor: 4.750

3.  Impaired Pentose Phosphate Pathway in the Spinal Cord of the hSOD1G93A Mouse Model of Amyotrophic Lateral Sclerosis.

Authors:  Tesfaye Wolde Tefera; Katherine Bartlett; Shirley S Tran; Mark P Hodson; Karin Borges
Journal:  Mol Neurobiol       Date:  2019-01-26       Impact factor: 5.590

4.  Open-label long-term treatment of add-on triheptanoin in adults with drug-resistant epilepsy.

Authors:  Karin Borges; Neha Kaul; Jack Germaine; Catalina Carrasco-Pozo; Patrick Kwan; Terence J O'Brien
Journal:  Epilepsia Open       Date:  2020-04-12

Review 5.  Impairments in Oxidative Glucose Metabolism in Epilepsy and Metabolic Treatments Thereof.

Authors:  Tanya McDonald; Michelle Puchowicz; Karin Borges
Journal:  Front Cell Neurosci       Date:  2018-08-31       Impact factor: 5.505

6.  Randomized trial of add-on triheptanoin vs medium chain triglycerides in adults with refractory epilepsy.

Authors:  Karin Borges; Neha Kaul; Jack Germaine; Patrick Kwan; Terence J O'Brien
Journal:  Epilepsia Open       Date:  2019-02-22

Review 7.  CNS glucose metabolism in Amyotrophic Lateral Sclerosis: a therapeutic target?

Authors:  Tesfaye Wolde Tefera; Frederik J Steyn; Shyuan T Ngo; Karin Borges
Journal:  Cell Biosci       Date:  2021-01-11       Impact factor: 7.133

8.  Metabolic perturbations associated with the consumption of a ketogenic medium-chain TAG diet in dogs with idiopathic epilepsy.

Authors:  Tsz Hong Law; Holger A Volk; Yuanlong Pan; Brian Zanghi; Elizabeth J Want
Journal:  Br J Nutr       Date:  2018-07-13       Impact factor: 3.718

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.